Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active rheumatoid arthritis in adults. where, its methotrexate a drug used to treat active arthritis. Reference standards of Upadacitinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => (3S,4R)-3-Ethyl-4-(3-nitroso-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide [catalogue_number] => PA 21 0181009 [category_ids] => ,70,75,76,78,82,162, [chemical_name] => [weight] => 409.37 [form] => C17H18F3N7O2 [cas] => NA [pslug] => 3s-4r-3-ethyl-4-3-nitroso-3h-imidazo-1-2-a-pyrrolo-2-3-e-pyrazin-8-yl-n-2-2-2-trifluoroethyl-pyrrolidine-1-carboxamide-pa210181009 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 21 0181009
CAS :
Molecular Formula : C17H18F3N7O2
Molecular Weight : 409.37
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
